| __timestamp | Amicus Therapeutics, Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 1860000 |
| Thursday, January 1, 2015 | 47269000 | 2963000 |
| Friday, January 1, 2016 | 71151000 | 6961000 |
| Sunday, January 1, 2017 | 88671000 | 11779000 |
| Monday, January 1, 2018 | 127200000 | 13697000 |
| Tuesday, January 1, 2019 | 169861000 | 15749000 |
| Wednesday, January 1, 2020 | 156407000 | 18638000 |
| Friday, January 1, 2021 | 192710000 | 27196000 |
| Saturday, January 1, 2022 | 213041000 | 31739000 |
| Sunday, January 1, 2023 | 275270000 | 33491000 |
Unleashing insights
In the competitive world of biotechnology, managing operational costs is crucial. Amicus Therapeutics, Inc. and Protagonist Therapeutics, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Amicus Therapeutics saw a staggering 1,230% increase in SG&A expenses, reflecting its aggressive growth strategy. In contrast, Protagonist Therapeutics experienced a more modest rise of approximately 1,700%, indicating a steady expansion approach.
By 2023, Amicus Therapeutics' SG&A expenses were nearly eight times higher than those of Protagonist Therapeutics, highlighting the scale of their operations. This divergence in financial strategy underscores the varied paths companies can take in the biotech sector. As investors and stakeholders analyze these trends, understanding the implications of SG&A expenses becomes vital for predicting future growth and sustainability.
Comparing SG&A Expenses: Merck & Co., Inc. vs Amicus Therapeutics, Inc. Trends and Insights
Amgen Inc. or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Protagonist Therapeutics, Inc.
Genmab A/S or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Neurocrine Biosciences, Inc. vs Protagonist Therapeutics, Inc. Trends and Insights
ADMA Biologics, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Perrigo Company plc or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Xenon Pharmaceuticals Inc. vs Protagonist Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Amicus Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Amicus Therapeutics, Inc. or Wave Life Sciences Ltd.
Protagonist Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Protagonist Therapeutics, Inc. vs Evotec SE: SG&A Expense Trends